Source: Annual Congress 2002 - Asthma: Inflammation, hyperreactivity, treatment side effects
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. W. Park, D. J. Kim, J. H. Lee, Y. H. Kim, C. S. Park, S. J. Park (Bucheon Si, South Korea). Development of asthma in patients with eosinophilic bronchitis: prospective follow up study. Eur Respir J 2002; 20: Suppl. 38, 434

Member's Comments

No comment yet.

Related content which might interest you: Development of chronic airway obstructive in patients with eosinophilic bronchitis: a prospective follow up study Source: Eur Respir J 2003; 22: Suppl. 45, 423s Year: 2003 Omalizumab in severe allergic asthma associated with COPD: a multicentric cohort study Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Mepolizumab in COPD with eosinophilic bronchitis: A randomized clinical trial Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Aspiration and severe exacerbations in COPD: a prospective study Source: ERJ Open Res, 7 (1) 00735-2020; 10.1183/23120541.00735-2020 Year: 2021 Effectiveness of omalizumab in Canadian patients with allergic asthma: A retrospective study. Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Association of asthma diagnosis with chronic airflow obstruction: a multi-site cross-sectional study Source: Virtual Congress 2021 – Asthma burden and management I Year: 2021 Characteristics and outcomes of chronic cough in individuals with asthma: a population-based study Source: International Congress 2018 – Asthma and allergy in adults and children and their biomarkers Year: 2018 Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: A retrospective observational study Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Experience with Mepolizumab in a cohort of patients with eosinophilic severe persistent asthma Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Chronic bronchitis phenotype in subjects with and without COPD: The PLATINO study Source: Annual Congress 2012 - COPD epidemiology Year: 2012 A retrospective cohort study demonstrating the impact of an OPEP device on exacerbations in COPD patients with chronic bronchitis Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Persistence of clinical criteria of chronic bronchitis in patients with COPD over time: A longitudinal analysis of the TRACE cohort. Source: International Congress 2017 – Markers of COPD progression Year: 2017 The characteristics of work-related asthma in a prospective asthma cohort Source: International Congress 2016 – Occupational epidemiology Year: 2016 Impact of chronic cough in individuals with COPD: a population-based cohort study Source: International Congress 2019 – More and more COPD Year: 2019 Predictor of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Patients with allergic and eosinophilic asthma in the German severe asthma registry Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 A pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitis Source: Eur Respir J , 49 (3) 1602486; DOI: 10.1183/13993003.02486-2016 Year: 2017 Asthma control and exacerbation rate with omalizumab in Italian patients with severe allergic asthma: PROXIMA study Source: International Congress 2017 – Asthma management Year: 2017 Effect of allergic sensitization on clinical course of patients with COPD in the Hokkaido COPD cohort study Source: International Congress 2014 – COPD physiopathology Year: 2014